sparfloxacin has been researched along with pd 0305970 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Armstrong, D; Balibar, CJ; Bauer, D; Bellamacina, C; Benton, BM; Bussiere, D; De Pascale, G; De Vicente, J; Dean, CR; Dhumale, B; Fisher, LM; Fuller, J; Fulsunder, M; Holder, LM; Hu, C; Kantariya, B; Lapointe, G; Leeds, JA; Li, X; Lu, P; Lvov, A; Ma, S; Madhavan, S; Malekar, S; McKenney, D; Mergo, W; Metzger, L; Moser, HE; Mutnick, D; Noeske, J; Osborne, C; Patel, A; Patel, D; Patel, T; Prajapati, K; Prosen, KR; Reck, F; Richie, DL; Rico, A; Rivkin, A; Sanderson, MR; Satasia, S; Sawyer, WS; Selvarajah, J; Shah, N; Shanghavi, K; Shu, W; Skepper, CK; Thompson, KV; Traebert, M; Vala, A; Vala, L; Veselkov, DA; Vo, J; Wang, M; Widya, M; Williams, SL; Xu, Y; Yue, Q; Zang, R; Zhou, B | 1 |
1 other study(ies) available for sparfloxacin and pd 0305970
Article | Year |
---|---|
Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria.
Topics: Anti-Bacterial Agents; Binding Sites; Cell Line, Tumor; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2020 |